This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cao, D. Articles by Pizzorno, G. Search for Related Content PubMed PubMed Citation Articles by Cao, D. Articles by Pizzorno, G.

Genomic Structure, Chromosomal Mapping, and Promoter Region Analysis of Murine Uridine Phosphorylase Gene¹

Departments of Internal Medicine (Oncology) and Pharmacology [D. C., F. W., D. Z., R. E. H., G. P.] and Genetics [M. A. N., P. B-W.], Yale University School of Medicine, New Haven, Connecticut 06520

Uridine phosphorylase (UPase) plays an important role in the activation of 5-fluorouracil and in the regulation of tissue and plasma concentration of uridine, a potential biochemical modulator of 5-fluorouracil therapy. UPase expression is affected by the c-H-rasoncogene and various cytokines through unknown mechanisms. To understand its expression and regulation, we cloned the murine UPase gene, defined its genomic organization, determined its 5'- and 3'-end flanking sequences, and evaluated the promoter activity. The UPase gene contains nine exons and eight introns, spanning a total of approximately 18.0 kb. Its promoter lacks canonical TATA and CCAAT boxes, although a CAATAAAAA TATA-like box is seen from -41 to -49. Furthermore, IFN regulatory factor 1, c/v-Myb, and p53 binding sites are present in the promoter region, indicating that UPase expression may be directly regulated by cytokines and oncogene products. The 1.2-kb flanking fragment showed promoter activity driving the expression of the luciferase gene in various mammalian cells. A TGGGG repeat sequence is seen in the 3'-end flanking region. This element is considered to be a potential recombination consensus hot spot that may contribute to the encoding of different UPase isoforms present in different tissues, both normal and neoplastic.

This article has been cited by other articles:

				L. Wan, D. Cao, J. Zeng, R. Yan, and G. Pizzorno Modulation of Uridine Phosphorylase Gene Expression by Tumor Necrosis Factor-{alpha} Enhances the Antiproliferative Activity of the Capecitabine Intermediate 5'-Deoxy-5-fluorouridine in Breast Cancer Cells Mol. Pharmacol., April 1, 2006; 69(4): 1389 - 1395. [Abstract] [Full Text] [PDF]

				D. Cao, J. J. Leffert, J. McCabe, B. Kim, and G. Pizzorno Abnormalities in Uridine Homeostatic Regulation and Pyrimidine Nucleotide Metabolism as a Consequence of the Deletion of the Uridine Phosphorylase Gene J. Biol. Chem., June 3, 2005; 280(22): 21169 - 21175. [Abstract] [Full Text] [PDF]

				D. Cao, R. L. Russell, D. Zhang, J. J. Leffert, and G. Pizzorno Uridine Phosphorylase (-/-) Murine Embryonic Stem Cells Clarify the Key Role of this Enzyme in the Regulation of the Pyrimidine Salvage Pathway and in the Activation of Fluoropyrimidines Cancer Res., April 1, 2002; 62(8): 2313 - 2317. [Abstract] [Full Text] [PDF]

				D. Zhang, D. Cao, R. Russell, and G. Pizzorno p53-dependent Suppression of Uridine Phosphorylase Gene Expression through Direct Promoter Interaction Cancer Res., September 1, 2001; 61(18): 6899 - 6905. [Abstract] [Full Text] [PDF]